TAŞKIRAN, Ç. Et Al. 2016. HOW CAN OPTIMAL CYTOREDUCTION RATES INCREASED OVER NINETY PERCENT WITH A MINIMAL USAGE OF NEOADJUVANT CHEMOTHERAPY. IGCS .

TAŞKIRAN, Ç., Mısırlıoğlu, S., ONAN, M. A., KARATAŞ, F., İŞÇİ BOSTANCI, E., KEREM, M., ... Balık, e.(2016). HOW CAN OPTIMAL CYTOREDUCTION RATES INCREASED OVER NINETY PERCENT WITH A MINIMAL USAGE OF NEOADJUVANT CHEMOTHERAPY . IGCS

TAŞKIRAN, ÇAĞATAY Et Al. "HOW CAN OPTIMAL CYTOREDUCTION RATES INCREASED OVER NINETY PERCENT WITH A MINIMAL USAGE OF NEOADJUVANT CHEMOTHERAPY," IGCS, 2016

TAŞKIRAN, ÇAĞATAY Et Al. "HOW CAN OPTIMAL CYTOREDUCTION RATES INCREASED OVER NINETY PERCENT WITH A MINIMAL USAGE OF NEOADJUVANT CHEMOTHERAPY." IGCS , 2016

TAŞKIRAN, Ç. Et Al. (2016) . "HOW CAN OPTIMAL CYTOREDUCTION RATES INCREASED OVER NINETY PERCENT WITH A MINIMAL USAGE OF NEOADJUVANT CHEMOTHERAPY." IGCS .

@conferencepaper{conferencepaper, author={ÇAĞATAY TAŞKIRAN Et Al. }, title={HOW CAN OPTIMAL CYTOREDUCTION RATES INCREASED OVER NINETY PERCENT WITH A MINIMAL USAGE OF NEOADJUVANT CHEMOTHERAPY}, congress name={IGCS}, city={}, country={}, year={2016}}